Clinical Trials Browser

Phase 1 × LY3295668 erbumine × 1 year × Clear all

NCT04106219 2025-07-23

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Phase 1 Active not recruiting

Epilepsy, Neuroblastoma